drugset / Trial / NCT03706261
Alzheimer's PET Imaging in Racially/Ethnically Diverse Adults
NaSingle-groupOpen-labelBasic science
Summary
The study employs tau positron emission tomography (PET) imaging in a well-characterized multi-racial/ethnic cohort to examine the extent to which tau pathology is associated with cognition, differences in tau pathology across racial/ethnic groups, and the relationship between MRI markers of small-vessel cerebrovascular disease and tau pathology. The study also investigates amyloid-dependent tau spreading.
Timeline
- Start
- 2019-03-22
- Primary completion
- 2023-07-14
- Completion
- 2023-07-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-Florbetaben | Diagnostic / imaging agent | 299.7 mbq | Intravenous |
| Subject | 18F-MK-6240 | Diagnostic / imaging agent | 185 mbq | — |